08:15 – Welcome coffee in the exhibition hall
08:45 – Opening ceremony
Patrizio Lancellotti, Luc A Piérard, Khalil Fattouch, Gilbert Habib, José-Luis Zamorano, Philippe Pibarot, Mani Vannan, Jeroen J. Bax
08:50 – Local hosts presentation of the venue
Jean-Paul Lavigne, Marc Radermecker
09:00 – Symposium « update on valvular heart disease registries: the big picture (ESC Core Curriculum in VHD) »
Chairmen: Gilbert Habib, Khalil Fattouch, Giovanni La Canna
- 09:00 – The global burden of VHD in Europe / Bernard Iung
- 09:18 – Tricuspid regurgitation: less and less forgotten / José-Luis Zamorano
- 09:36 – Infective endocarditis: changing epidemiology and outcome? / Gilbert Habib
- 09:54 – Bicuspid aortic valve: demographics and natural history / Jeroen J Bax
- 10:12 – Round table discussion with experts’ panel / Gilles Dreyfus, Agnès Pasquet, Philippe Pibarot
10:30 – Coffee break in the exhibition hall
Poster Display of accepted abstract
11:00 – Case base session: heart failure and mitral regurgitation
Chairmen: Mark Claeys, Jean-Olivier Defraigne, Luc A. Piérard
- 11:00 – Case presentation / Raluca Elena Dulgheru
- 11:08 – Imaging assessment / Eustachio Agricola
- 11:20 – Guidelines-directed medical treatment / David Montaigne
- 11:32 – When and why to provide cardiac resynchronization therapy? / Patrizio Lancellotti
- 11:44 – The when and how for surgical treatment / Ottavio Alfieri
- 11:56 – The when and how for percutaneous treatment / Francesco Maisano
- 12:08 – Round table discussion with expert’s panel / Rodolphe Durieux, Madalina Garbi, Jean-Paul Lavigne, Thomas Modine, Geu-Ru Hong
12:30 – Industry symposium
13:00 – Lunch break in the exhibition hall
Poster Display of accepted abstract
14:00 – Challenges in valvular heart disease
Chairmen: Raphaël Rosenhek, Jean-Louis Vanoverschelde
- 14:00 – Indication of familial screening in BAV / Jean-Luc Monin
- 14:12 – Prophylaxis for infective endocarditis / Bernard Iung
- 14:24 – Medical treatment: why bother? / Julien Magne
- 14:36 – Ejection fraction vs. strain in surgical indication / TBD
- 14:48 – Paradoxical low-flow, low-gradient AS: a challenging entity / Philippe Pibarot
- 15:00 – New antithrombotic regimes for mechanical valves / John Chambers
- 15:12 – Round table discussion with experts’ panel / Massimo Mancone, Christophe Martinez, Thomas Modine, Anna Sonia Petronio, Raphaël Rosenhek, Elif Sade
15:30 – Pending issues in transcatheter aortic valve treatment (ESC Core Curriculum in VHD)
Chairmen: Joelle Kefer, Julia Mascherbauer, José-Luis Zamorano
- 15:30 – TAVI vs. SAVR for low risk populations – the evidence / Ariana Gonzalez Gomez
- 15:45 – TAVI for asymptomatic severe aortic stenosis – the next frontier / Philippe Pibarot
- 16:00 – Long-term durability of TAVI versus SAVR: the unknown / Thomas Modine
- 16:15 – Tailoring antithrombotic therapy to the TAVI patient / Cécile Oury
- 16:30 – Round table discussion with experts’ panel / Olivier Gach, David Montaigne, Philippe Kolh, Jean-Louis Vanoverschelde
16:45 – Coffee break in the exhibition hall
Poster Display of accepted abstract
17:15 – Challenging the experts (ESC Core Curriculum in VHD)
Chairmen: Michele De Bonnis, Mani Vannan, Isidre Vilacosta
- 17:15 – A patient with moderate aortic stenosis and systolic heart failure / Marie-Annick Clavel
- 17:25 – A patient with moderate mitral regurgitation and LV systolic dysfunction / Giovanna La Canna
- 17:35 – A patient with tricuspid regurgitation and RV dysfunction / Xiao Zhou
- 17:45 – A patients with prosthetic heart valve and positive PET/ Pilar Tornos
- 17:55 – A symptomatic patient with paravalvular mitral regurgitation / Mathieu Lempereur
- 18:05 – Round table discussion with experts’ panel / Laurent Davin, Covadonga Fernández-Golfín, Gilbert Habib, Vincent Tchana-Sato
18:20 – End of the sessions
